Skip to content

Prospective cohort studies based on factors associated with wet syndrome explored the construction of a predictive model for eczema recurrence

Prospective cohort studies based on factors associated with wet syndrome explored the construction of a predictive model for eczema recurrence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005732
Enrollment
Unknown
Registered
2022-03-16
Start date
2022-03-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema

Interventions

Observation group:Traditional Chinese medicine "damp removal method" treatment or Western medicine routine treatment
Non-Dampness Syndrome group:TCM Syndrome Differentiation Treatment or Western Medicine Routine Treatment

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for eczema; 2. IGA score = 2 points; 3. Age over 18 years old, gender is not limited; 4. The function of important organs such as the heart, liver, lungs, and kidneys is basically normal; 5. Voluntarily participate in this research project, have good compliance, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Other skin diseases that affect the judgment of skin lesions such as psoriasis and seborrheic dermatitis; 2. Those who have primary diseases, immunodeficiency, autoimmune diseases, metabolic diseases, malignant tumors and mental diseases of important organs such as cardiovascular and cerebrovascular diseases, liver and kidneys; 3. Pregnant, preparing to become pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Eczema recurrence;

Secondary

MeasureTime frame
Chinese medicine wet syndrome score;IGA-EASI-VAS score before and after recurrence;Cytokine and chemokines levels before and after recurrence;

Countries

China

Contacts

Public ContactChen Dacan
4910702@163.com13602864954

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026